CCAAT/增强子结合蛋白同源蛋白(CHOP)在二乙基亚硝胺诱导的肝细胞癌模型中促进肿瘤发生。
CCAAT/enhancer-binding protein homologous (CHOP) protein promotes carcinogenesis in the DEN-induced hepatocellular carcinoma model.
作者信息
Scaiewicz Viviana, Nahmias Avital, Chung Raymond T, Mueller Tobias, Tirosh Boaz, Shibolet Oren
机构信息
Institute for Drug Research, School of Pharmacy, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
出版信息
PLoS One. 2013 Dec 5;8(12):e81065. doi: 10.1371/journal.pone.0081065. eCollection 2013.
BACKGROUND AND AIMS
C/EBP homologous protein (CHOP) plays pro-apoptotic roles in the integrated stress response. Recently, a tumor suppressive role for CHOP was demonstrated in lung cancer via regulation of tumor metabolism. To explore the role of CHOP in hepatocarcinogenesis, we induced hepatocellular carcinoma (HCC) in wild type (wt) and CHOP knockout (KO) mice using the carcinogen N-diethylnitrosamine (DEN).
RESULTS
Analysis of tumor development showed reduced tumor load, with markedly smaller tumor nodules in the CHOP KO animals, suggesting oncogenic roles of CHOP in carcinogen-induced HCC. In wt tumors, CHOP was exclusively expressed in tumor tissue, with minimal expression in normal parenchyma. Analysis of human adenocarcinomas of various origins demonstrated scattered expression of CHOP in the tumors, pointing to relevance in human pathology. Characterization of pathways that may contribute to preferential expression of CHOP in the tumor identified ATF6 as a potential candidate. ATF6, a key member of the endoplasmic reticulum stress signaling machinery, exhibited a similar pattern of expression as CHOP and strong activation in wt but not CHOP KO tumors. Because HCC is induced by chronic inflammation, we assessed whether CHOP deficiency affects tumor-immune system crosstalk. We found that the number of macrophages and levels of IFNγ and CCL4 mRNA were markedly reduced in tumors from CHOP KO relative to wt mice, suggesting a role for CHOP in modulating tumor microenvironment and macrophage recruitment to the tumor.
CONCLUSION
Our data highlights a role for CHOP as a positive regulator of carcinogen-induced HCC progression through a complex mechanism that involves the immune system and modulation of stress signaling pathways.
背景与目的
C/EBP 同源蛋白(CHOP)在整合应激反应中发挥促凋亡作用。最近,通过调节肿瘤代谢,CHOP 在肺癌中显示出肿瘤抑制作用。为了探究 CHOP 在肝癌发生中的作用,我们使用致癌物 N-二乙基亚硝胺(DEN)在野生型(wt)和 CHOP 基因敲除(KO)小鼠中诱导肝细胞癌(HCC)。
结果
肿瘤发展分析显示,CHOP 基因敲除动物的肿瘤负荷降低,肿瘤结节明显更小,提示 CHOP 在致癌物诱导的 HCC 中具有致癌作用。在野生型肿瘤中,CHOP 仅在肿瘤组织中表达,在正常实质中表达极少。对各种来源的人类腺癌分析表明,CHOP 在肿瘤中呈散在表达,表明其与人类病理学相关。对可能导致 CHOP 在肿瘤中优先表达的信号通路进行表征,确定 ATF6 为潜在候选者。ATF6 是内质网应激信号机制的关键成员,其表达模式与 CHOP 相似,在野生型肿瘤中强烈激活,但在 CHOP 基因敲除肿瘤中未激活。由于 HCC 是由慢性炎症诱导的,我们评估了 CHOP 缺陷是否影响肿瘤-免疫系统的相互作用。我们发现,与野生型小鼠相比,CHOP 基因敲除小鼠肿瘤中的巨噬细胞数量以及 IFNγ 和 CCL4 mRNA 水平明显降低,提示 CHOP 在调节肿瘤微环境和巨噬细胞向肿瘤募集方面发挥作用。
结论
我们的数据突出了 CHOP 通过涉及免疫系统和应激信号通路调节的复杂机制,作为致癌物诱导的 HCC 进展的正调节因子的作用。
相似文献
Arch Biochem Biophys. 2023-9-1
Cell Death Differ. 2017-12-11
Gastroenterology. 2018-11-13
引用本文的文献
Front Mol Med. 2022-9-26
本文引用的文献
J Hepatol. 2013-5-9
Nat Cell Biol. 2013-4-28
Pharmacol Ther. 2012-2-17